SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS.Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford)2004;43:90614.
  • 2
    Van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, et al.The effectiveness of early treatment with “second-line” antirheumatic drugs: a randomized, controlled trial. Ann Intern Med1996;124:699707.
  • 3
    Lard LR, Visser H, Speyer I, van der Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al.Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med2001;111:44651.
  • 4
    Aletaha D, Funovits J, Breedveld FC, Sharp J, Segurado O, Smolen JS.Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment. Arthritis Rheum2009;60:12429.
  • 5
    Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al.EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis2010;69:32531.
  • 6
    Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis2010;69:96475.
  • 7
    Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, et al, for the ATTRACT Study Group.Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the Anti–Tumor Necrosis Factor Trial in Rheumatoid Arthritis With Concomitant Therapy study. Arthritis Rheum2005;52:102030.
  • 8
    Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al, for the PREMIER Investigators.The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum2006;54:2637.
  • 9
    Van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, et al, for the TEMPO Study Investigators.Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum2006;54:106374.
  • 10
    Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, et al.Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis2011;70:3946.
  • 11
    Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, et al, for the DANCER Study Group.The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum2006;54:1390400.
  • 12
    Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, et al, for the REFLEX Trial Group.Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum2006;54:2793806.
  • 13
    Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dorner T, et al.Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis2011;70:90920.
  • 14
    Vital EM, Dass S, Rawstron AC, Buch MH, Goeb V, Henshaw K, et al.Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment. Arthritis Rheum2010;62:12739.
  • 15
    Emery P, Mease PJ, Rubbert-Roth A, Curtis JR, Muller-Ladner U, Gaylis NB, et al.Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis. Rheumatology (Oxford)2011;50:222332.
  • 16
    Narvaez J, Diaz-Torne C, Ruiz JM, Hernandez MV, Torrente-Segarra V, Ros S, et al.Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs. Clin Exp Rheumatol2011;29:9917.
  • 17
    Lal P, Su Z, Holweg CT, Silverman GJ, Schwartzman S, Kelman A, et al.Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis Rheum2011;63:368191.
  • 18
    Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, et al.Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann Rheum Dis2011;70:157580.
  • 19
    Solau-Gervais E, Prudhomme C, Philippe P, Duhamel A, Dupont-Creteur C, Legrand JL, et al.Efficacy of rituximab in the treatment of rheumatoid arthritis: influence of serologic status, coprescription of methotrexate and prior TNF-α inhibitors exposure. Joint Bone Spine2012;79:2814.
  • 20
    Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al.2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum2010;62:256981.
  • 21
    Scott DL.Radiological progression in established rheumatoid arthritis. J Rheumatol Suppl2004;69:5565.
  • 22
    Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA.Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study. J Rheumatol2011;38:4452.
  • 23
    Guillemin F, Gerard N, van Leeuwen M, Smedstad LM, Kvien TK, van den Heuvel W, for the EURIDISS Group.Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients. J Rheumatol2003;30:25859.
  • 24
    Plant MJ, Jones PW, Saklatvala J, Ollier WE, Dawes PT.Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol1998;25:41726.
  • 25
    Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, et al.Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford)2007;46:3429.
  • 26
    Backhaus M, Burmester GR, Sandrock D, Loreck D, Hess D, Scholz A, et al.Prospective two year follow up study comparing novel imaging procedures in patients with arthritic finger joints. Ann Rheum Dis2002;61:895904.
  • 27
    Szkudlarek M, Klarlund M, Narvestad E, Court-Payen M, Strandberg C, Jensen KE, et al.Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther2006;8:R52.
  • 28
    Szkudlarek M, Narvestad E, Klarlund M, Court-Payen M, Thomsen HS, Ostergaard M.Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum2004;50:210312.
  • 29
    Wakefield RJ, Gibbon WW, Conaghan PG, O'Connor P, McGonagle D, Pease C, et al.The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum2000;43:276270.
  • 30
    Backhaus M, Kamradt T, Sandrock D, Loreck D, Fritz J, Wolf KJ, et al.Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum1999;42:123245.
  • 31
    Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W, et al.Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum2009;61:1194201.
  • 32
    Scheel AK, Hermann KG, Ohrndorf S, Werner C, Schirmer C, Detert J, et al.Prospective 7 year follow up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger joints. Ann Rheum Dis2006;65:595600.
  • 33
    Scheel AK, Hermann KG, Kahler E, Pasewaldt D, Fritz J, Hamm B, et al.A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis Rheum2005;52:73343.
  • 34
    Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen H, Ostergaard M.Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum2003;48:95562.
  • 35
    Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S, et al.Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum2012;64:6776.
  • 36
    Fukae J, Isobe M, Kitano A, Henmi M, Sakamoto F, Narita A, et al.Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: potential utility of power Doppler sonography in clinical practice. Arthritis Care Res (Hoboken)2011;63:124753.
  • 37
    Vreju F, Ciurea M, Rosu A, Musetescu A, Grecu D, Ciurea P.Power Doppler sonography, a non-invasive method of assessment of the synovial inflammation in patients with early rheumatoid arthritis. Rom J Morphol Embryol2011;52:63743.
  • 38
    Naredo E, Moller I, Cruz A, Carmona L, Garrido J.Power Doppler ultrasonographic monitoring of response to anti–tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum2008;58:224856.
  • 39
    Filippucci E, Iagnocco A, Salaffi F, Cerioni A, Valesini G, Grassi W.Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis2006;65:14337.
  • 40
    Scire CA, Montecucco C, Codullo V, Epis O, Todoerti M, Caporali R.Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology (Oxford)2009;48:10927.
  • 41
    Karim Z, Wakefield RJ, Conaghan PG, Lawson CA, Goh E, Quinn MA, et al.The impact of ultrasonography on diagnosis and management of patients with musculoskeletal conditions. Arthritis Rheum2001;44:29323.
  • 42
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988;31:31524.
  • 43
    Smolen JS, Keystone EC, Emery P, Breedveld FC, Betteridge N, Burmester GR, et al.Consensus statement on the use of rituximab in patients with rheumatoid arthritis [review]. Ann Rheum Dis2007;66:14350.
  • 44
    Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, et al.Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis2001;60:6419.
  • 45
    Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, et al.Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol2005;32:24857.
  • 46
    Torp-Pedersen ST, Terslev L.Settings and artefacts relevant in colour/power Doppler ultrasound in rheumatology. Ann Rheum Dis2008;67:1439.
  • 47
    Sommier JP, Michel-Batot C, Sauliere N, Rat AC, Hoenen-Clavert V, Pourel J, et al.Structural lesions in RA: proposition for a new semiquantitative score (ScuSSEe: Scoring by Ultrasound Structural erosion) [abstract]. Arthritis Rheum2006;54 Suppl:S140.
  • 48
    Van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL.Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum1996;39:3440.
  • 49
    Chary-Valckenaere I, Sommier JP, Michel-Batot C, Sauliere N, Rat AC, Hoenen-Clavert V, et al.Erosion and joint space narrowing in RA: proposition for a new semiquantitative score (ScuSST: Scoring by UltraSound Structural Total) [abstract]. Arthritis Rheum2006;54 Suppl:S139.
  • 50
    Van der Heijde DM.Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol1995;34 Suppl:748.
  • 51
    Riente L, Delle Sedie A, Scire CA, Filippucci E, Meenagh G, Iagnocco A, et al.Ultrasound imaging for the rheumatologist. XXXI. Sonographic assessment of the foot in patients with rheumatoid arthritis. Clin Exp Rheumatol2011;29:15.
  • 52
    Dougados M, Jousse-Joulin S, Mistretta F, d'Agostino MA, Backhaus M, Bentin J, et al.Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicenter study of rheumatoid arthritis. Ann Rheum Dis2010;69:82833.